Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine.
Invasive pneumococcal disease (IPD) epidemiology and the potential impact of the pneumococcal conjugate vaccine in Fiji are documented. The annual incidence was 26.5 and 10.9 in those aged <5 and > or =55 years per 100,000, respectively. The case fatality rate was 9.4% and 67% in <5 and >65 year olds, respectively. One pneumococcal death and case would be prevented in <5 years olds for every 1930 and 128 infants vaccinated with 7vPCV, respectively.
Russell
Fiona Mary
FM
Department of Paediatrics, Centre for International Child Health, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Victoria, Australia. fmruss@unimelb.edu.au
Carapetis
Jonathan Rhys
JR
Tikoduadua
Lisi
L
Paeds
Dip
D
Chandra
Reginald
R
Seduadua
Anna
A
Satzke
Catherine
C
Pryor
Jan
J
Buadromo
Eka
E
Waqatakirewa
Lepani
L
Mulholland
Edward Kim
EK
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D005367:Fiji / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009026:Mortality; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology* / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000276:immunology*; D014611:Vaccination / Q000706:statistics & numerical data; D018074:Vaccines, Conjugate / Q000276:immunology; D055815:Young Adult
D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate